Michael Caldera

Michael Caldera

Auto-generated profile, based on publicly available information

Michael Caldera

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences Lazarettgasse 14 1090 Vienna Austria

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Immunity
Verified
Journal Article
Open access
ALAlexander Lercher
Alexander Lercher
ABAnannya Bhattacharya
Anannya Bhattacharya
APAlexandra M. Popa
Alexandra M. Popa
MCMichael Caldera
Michael Caldera
MSMoritz F. Schlapansky
Moritz F. Schlapansky
ABAndreas Bergthaler
Andreas Bergthaler
Infections induce complex host responses linked to antiviral defense, inflammation, and tissue damage and repair. We hypothesized that the liver, as a central metabolic hub, may orchestrate systemic metabolic changes during infection. We infected mice with chronic lymphocytic choriomeningitis virus (LCMV), performed RNA sequencing and proteomics of liver tissue, and integrated these data with serum metabolomics at different infection phases. Widespread reprogramming of liver metabolism occurred early after infection, correlating with type I interferon (IFN-I) responses. Viral infection induced metabolic alterations of the liver that depended on the interferon alpha/beta receptor (IFNAR1). Hepatocyte-intrinsic IFNAR1 repressed the transcription of metabolic genes, including Otc and Ass1, which encode urea cycle enzymes. This led to decreased arginine and increased ornithine concentrations in the circulation, resulting in suppressed virus-specific CD8+ T cell responses and ameliorated liver pathology. These findings establish IFN-I-induced modulation of hepatic metabolism and the urea cycle as an endogenous mechanism of immunoregulation. VIDEO

1 June 2017 in Current Opinion in Systems Biology
Verified
Journal Article
Open access
MCMichael Caldera
Michael Caldera
PBPisanu Buphamalai
Pisanu Buphamalai
FMFelix Müller
Felix Müller
JMJörg Menche
Jörg Menche

1 October 2018 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
APAntonia Puchner
Antonia Puchner
VSVictoria Saferding
Victoria Saferding
MBMichael Bonelli
Michael Bonelli
YMYohei Mikami
Yohei Mikami
MHMelanie Hofmann
Melanie Hofmann
SBStephan Blüml
Stephan Blüml
Objectives Bone destruction in rheumatoid arthritis is mediated by osteoclasts (OC), which are derived from precursor cells of the myeloid lineage. The role of the two monocyte subsets, classical monocytes (expressing CD115, Ly6C and CCR2) and non-classical monocytes (which are CD115 positive, but low in Ly6C and CCR2), in serving as precursors for OC in arthritis is still elusive. Methods We investigated CCR2−/− mice, which lack circulating classical monocytes, crossed into hTNFtg mice for the extent of joint damage. We analysed monocyte subsets in hTNFtg and K/BxN serum transfer arthritis by flow cytometry. We sorted monocyte subsets and analysed their potential to differentiate into OC and their transcriptional response in response to RANKL by RNA sequencing. With these data, we performed a gene ontology enrichment analysis and gene set enrichment analysis. Results We show that in hTNFtg arthritis local bone erosion and OC generation are even enhanced in the absence of CCR2. We further show the numbers of non-classical monocytes in blood are elevated and are significantly correlated with histological signs of joint destruction. Sorted non-classical monocytes display an increased capacity to differentiate into OCs. This is associated with an increased expression of signal transduction components of RANK, most importantly TRAF6, leading to an increased responsiveness to RANKL. Conclusion Therefore, non-classical monocytes are pivotal cells in arthritis tissue damage and a possible target for therapeutically intervention for the prevention of inflammatory joint damage.

13 November 2019 in Nature Communications
Verified
Journal Article
Open access
MCMichael Caldera
Michael Caldera
FMFelix Müller
Felix Müller
IKIsabel Kaltenbrunner
Isabel Kaltenbrunner
MLMarco P. Licciardello
Marco P. Licciardello
CLCharles-Hugues Lardeau
Charles-Hugues Lardeau
JMJörg Menche
Jörg Menche
Drug combinations provide effective treatments for diverse diseases, but also represent a major cause of adverse reactions. Currently there is no systematic understanding of how the complex cellular perturbations induced by different drugs influence each other. Here, we introduce a mathematical framework for classifying any interaction between perturbations with high-dimensional effects into 12 interaction types. We apply our framework to a large-scale imaging screen of cell morphology changes induced by diverse drugs and their combination, resulting in a perturbome network of 242 drugs and 1832 interactions. Our analysis of the chemical and biological features of the drugs reveals distinct molecular fingerprints for each interaction type. We find a direct link between drug similarities on the cell morphology level and the distance of their respective protein targets within the cellular interactome of molecular interactions. The interactome distance is also predictive for different types of drug interactions.

22 May 2017 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
MLMarco P Licciardello
Marco P Licciardello
ARAnna Ringler
Anna Ringler
PMPatrick Markt
Patrick Markt
FKFreya Klepsch
Freya Klepsch
CLCharles-Hugues Lardeau
Charles-Hugues Lardeau
SKStefan Kubicek
Stefan Kubicek

3 July 2020 in Science Immunology
Verified
Journal Article
Closed access
ESElisabeth Salzer
Elisabeth Salzer
SZSamaneh Zoghi
Samaneh Zoghi
MKMáté G. Kiss
Máté G. Kiss
FKFrieda Kage
Frieda Kage
CRChristina Rashkova
Christina Rashkova
KBKaan Boztug
Kaan Boztug
HEM1 deficiency causes heritable autoimmunity and immunodeficiency.